Literature DB >> 3722866

Antigen-induced experimental septic arthritis in rabbits after intraarticular injection of Staphylococcus aureus.

M L Mahowald, L Peterson, J Raskind, D A Raddatz, R Shafer, D Gerding.   

Abstract

With the Dumonde-Glynn model of antigen-induced arthritis, a rabbit model was developed to examine the histopathologic differences between normal and arthritic joints in the same animal infected by intraarticular injections of Staphylococcus aureus. Microscopic examination of whole joint sections and a quantitative histopathologic scale were used to compare changes in all the articular components of 17 normal and 17 arthritic joints infected for less than two weeks. The histological changes were more severe in infected arthritic joints than in infected normal joints (mean +/- SD total histology score, 13.8 +/- 2.4 and 9.3 +/- 4.0, respectively; P less than .001). In infected arthritic joints, subsynovial abscesses extended into subchondral bone via the pannus of chronic synovitis at articular margins and intraarticular attachments of cruciate ligaments, rather than by initial cartilage destruction and direct extension into subchondral bone.

Entities:  

Mesh:

Year:  1986        PMID: 3722866     DOI: 10.1093/infdis/154.2.273

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  3 in total

1.  Histopathological and serological progression of experimental Staphylococcus aureus arthritis.

Authors:  T Bremell; A Abdelnour; A Tarkowski
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

2.  Experimental Staphylococcus aureus arthritis in mice.

Authors:  T Bremell; S Lange; A Yacoub; C Rydén; A Tarkowski
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Mactinin: a modulator of the monocyte response to inflammation.

Authors:  Sharon D Luikart; Hollis E Krug; Robert D Nelson; Timothy Hinkel; Peter Majeski; Pankaj Gupta; Maren L Mahowald; Theodore Oegema
Journal:  Arthritis Res Ther       Date:  2003-08-05       Impact factor: 5.156

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.